bicycle therapeutics - Robuta Search

https://secure.businesswire.com/news/home/20250808838184/en/Bicycle-Therapeutics-Reports-Recent-Business-Progress-and-Second-Quarter-2025-Financial-Results Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic... bicycle therapeutics https://www.businesswire.com/news/home/20201124005288/en/Bicycle-Therapeutics-to-Present-at-the-2020-Piper-Sandler-Healthcare-Conference Bicycle Therapeutics to Present at the 2020 Piper Sandler Healthcare Conference Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic ... bicycle therapeutics piper sandler present https://www.sec.gov/Archives/edgar/data/1761612/000155837025001438/bcyc-20241231x10k.htm BICYCLE THERAPEUTICS PLC_December 31, 2024 bicycle therapeutics plc december https://actu.epfl.ch/news/epfl-spin-off-bicycle-therapeutics-floats-on-nasda/ EPFL spin-off Bicycle Therapeutics floats on Nasdaq - EPFL spin off bicycle therapeutics epfl floats nasdaq https://www.businesswire.com/news/home/20251030686670/en/Bicycle-Therapeutics-Reports-Recent-Business-Progress-and-Third-Quarter-2025-Financial-Results Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic... bicycle therapeutics https://www.bicycletherapeutics.com/ Bicycle Therapeutics bicycle therapeutics https://www.businesswire.com/news/home/20230905198369/en/Bicycle-Therapeutics-to-Participate-in-the-Morgan-Stanley-21st-Annual-Global-Healthcare-Conference Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference Bicycle Therapeutics (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic pept... https://www.benzinga.com/general/biotech/22/09/28786347/important-biotech-catalysts-for-september-7-2022-end-of-the-day-summary Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary - Bicycle Therapeutics... end of the day https://www.businesswire.com/news/home/20260420953740/en/Bicycle-Therapeutics-Provides-Update-on-Nuzefatide-Pevedotin-and-EphA2-Pipeline-at-the-AACR-Annual-Meeting-2026 Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual... Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic... https://adisinsight.springer.com/drugs/800054776?error=cookies_not_supported&code=be098b2d-69a8-41f4-9c62-6de916b8d7eb Research programme: dementia therapeutics - Bicycle Therapeutics - AdisInsight Peptide therapeutics are being developed by Bicycle Therapeutics for neurodegenerative diseases including dementia. The company is utilising its proprietary research programme dementia therapeutics bicycle adisinsight https://www.benzinga.com/24/12/42482129/bicycle-therapeutics-lead-cancer-cancer-drug-combined-with-mercks-blockbuster-drug-shows-60-overall-response-rate Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall... Dec 13, 2024 - Bicycle Therapeutics presented data on zelenectide pevedotin, highlighting enhanced efficacy in cancer patients with NECTIN4 gene amplification.